• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[用淋巴细胞转化试验对肝豆状核变性患者青霉胺治疗副作用的免疫学研究]

[Immunologic studies with the lymphocyte transformation test on the side effects of D-penicillamine therapy in Wilson's disease].

作者信息

Storch W, Berger H

出版信息

Z Gesamte Inn Med. 1980 Jul 1;35(13):567-70.

PMID:7445606
Abstract

18 patients with Wilson's disease with and without proteinuria and 19 test persons without Wilson's disease were examined for a disturbance of the transformation on account of phythemagglutinin, streptolysin-O and several D-penicillamine preparations by means of the lymphocyte transformation test. Also during the therapy with D-penicillamine was no cause for a disturbed transformation of lymphocytes on the mitogen phythemagglutinin. A cell-conditioned immune reaction to D-penicillamine which could be established by means of the lymphocyte transformation test under the conditions chosen seems to be present in patients with Wilson's disease neither in lacking or insignificant nor in pronounced proteinuria. The increased transformation rates to streptolysin-O in Wilson's disease need confirmation in a larger number of patients. Like the increased spontaneous transformation rates they might refer to an immune-stimulating effect of the D-penicillamine.

摘要

对18例患有和未患有蛋白尿的威尔逊氏病患者以及19例未患威尔逊氏病的测试对象,通过淋巴细胞转化试验,检测因植物血凝素、链球菌溶血素 - O和几种青霉胺制剂导致的转化障碍。在使用青霉胺治疗期间,也没有发现有丝分裂原植物血凝素导致淋巴细胞转化障碍的情况。在所选择的条件下,通过淋巴细胞转化试验可以确定,威尔逊氏病患者似乎不存在针对青霉胺的细胞条件免疫反应,无论其是否存在蛋白尿,蛋白尿程度是轻微还是严重。威尔逊氏病患者对链球菌溶血素 - O的转化率增加需要在更多患者中得到证实。与自发转化率增加一样,它们可能归因于青霉胺的免疫刺激作用。

相似文献

1
[Immunologic studies with the lymphocyte transformation test on the side effects of D-penicillamine therapy in Wilson's disease].[用淋巴细胞转化试验对肝豆状核变性患者青霉胺治疗副作用的免疫学研究]
Z Gesamte Inn Med. 1980 Jul 1;35(13):567-70.
2
[Serious side effects with D-penicillamine therapy for Wilson's disease].
Psychiatr Neurol Med Psychol (Leipz). 1979 Sep;31(9):531-8.
3
Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease.青霉胺诱发威尔逊病患儿及威尔逊病母亲所生健康婴儿的甲状腺功能减退和激素合成障碍。
J Pediatr. 2008 Dec;153(6):864-6. doi: 10.1016/j.jpeds.2008.06.015.
4
[Nephrotic syndrome secondary to d-penicillamine in a patient with Wilson's disease].[一名威尔逊病患者因青霉胺继发肾病综合征]
Rev Clin Esp. 1993 Oct;193(6):343-4.
5
[The detection of antibodies against D-penicillamine. 3. Detection of antibodies against D-penicillamine in the serum of patients with Wilson's disease treated with D-penicillamine--preliminary results].
Pharmazie. 1986 Feb;41(2):126-7.
6
Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.在没有替代孤儿药(曲恩汀 - 锌)的情况下停用青霉胺:1例威尔逊病失代偿期肝硬化病例
J Clin Pharm Ther. 2007 Feb;32(1):101-7. doi: 10.1111/j.1365-2710.2007.00794.x.
7
Membranoproliferative glomerulonephritis in a patient with Wilson's disease.一名威尔逊病患者的膜增生性肾小球肾炎。
J Nephrol. 2006 Nov-Dec;19(6):831-3.
8
Penicillamine hypersensitivity: successful desensitization of a patient with severe hepatic Wilson's disease.青霉胺超敏反应:1例重度肝豆状核变性患者脱敏成功
Am J Gastroenterol. 1994 Mar;89(3):442-3.
9
[immunohistologic findings of kidney biopsies in Wilson's disease].[肝豆状核变性患者肾活检的免疫组织学发现]
Z Urol Nephrol. 1980 Mar;73(3):181-90.
10
[Trientin in Wilson's disease. Therapeutic possibilities in patients who cannot tolerate penicillamine].
Tidsskr Nor Laegeforen. 1987 Aug 10;107(22):1770-1.